Gain Therapeutics, Inc.
What this means
- Net loss in 2025Net loss of $20.2M for the year (2024: −$20.4M).
What to do next
- How to check a US company before you sign a contractguide
- How to read an 8-K: what customers and creditors should checkguide
Guides from the Companies Daily newsroom, picked for what the register shows.
Financials from XBRL
| Calendar-year frame | 2025 | 2024 |
|---|---|---|
| Net income (loss) | −$20.2M | −$20.4M |
| Total assets | $22.8M | $12.1M |
| Total liabilities | $4.3M | $4.8M |
| Stockholders’ equity | $18.6M | $7.3M |
| Cash and equivalents | $20.8M | $10.4M |
From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.
- Name as filed
- Gain Therapeutics, Inc.
- CIK
- 0001819411
- Tickers
- GANX
- Kind of filer
- SEC-reporting company
Emerging growth company - Status
- Filing with the SEC
- State of incorporation
- Delaware
- Industry (SIC)
- 2834 · Pharmaceutical preparations
Industry: D · Manufacturing → - Fiscal year ends
- December 31
- Last annual report
- 10-K for the period ended Dec 31, 2025
- Last quarterly report
- 10-Q for the quarter ended Sep 30, 2026
- Bankruptcy reported
- Not in our data
- Last edition event
- Nov 10, 2026
Filing history
Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.
- Form 10-Q · filed Nov 10, 2026 · filing · edition of Nov 10, 2026
- Form 8-K · items 2.02, 9.01 · filed Nov 10, 2026 · filing · edition of Nov 10, 2026
- Form 8-K · items 5.02, 9.01 · filed Oct 28, 2026 · filing
- Form 8-K · items 5.02 · filed Sep 28, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 11, 2026 · filing
- Form 10-Q · filed Aug 11, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed May 11, 2026 · filing
- Form 10-Q · filed May 11, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed Mar 26, 2026 · filing
- Form 10-K · filed Mar 26, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed Nov 12, 2025 · filing
- Form 10-Q · filed Nov 12, 2025 · filing
- Form 8-K · items 5.02 · filed Oct 9, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 12, 2025 · filing
- Form 10-Q · filed Aug 12, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed May 14, 2025 · filing
- Form 10-Q · filed May 14, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed Mar 27, 2025 · filing
- Form 10-K · filed Mar 27, 2025 · filing
- Form 8-K · items 3.01 · filed Jan 15, 2025 · filing
- Form 8-K · items 5.02, 7.01, 9.01 · filed Jan 7, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed Nov 14, 2024 · filing
- Form 10-Q · filed Nov 14, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 8, 2024 · filing
- Form 10-Q · filed Aug 8, 2024 · filing
- Form 8-K · items 3.01 · filed Jul 12, 2024 · filing
- Form 8-K · items 5.02, 7.01, 9.01 · filed Jun 28, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed May 14, 2024 · filing
- Form 10-Q · filed May 14, 2024 · filing
- Form 8-K · items 5.02, 7.01, 9.01 · filed Apr 8, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed Mar 26, 2024 · filing
- Form 10-K · filed Mar 26, 2024 · filing
- Form 8-K · items 5.02 · filed Feb 22, 2024 · filing
- Form S-1 · filed Dec 19, 2023 · filing
- Form 8-K · items 2.02, 9.01 · filed Nov 14, 2023 · filing
- Form 10-Q · filed Nov 14, 2023 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 10, 2023 · filing
- Form 10-Q · filed Aug 10, 2023 · filing
- Form 8-K · items 2.02, 9.01 · filed May 12, 2023 · filing
- Form 10-Q · filed May 12, 2023 · filing
- Form 8-K · items 5.02, 9.01 · filed Apr 28, 2023 · filing
- Form 8-K · items 5.02, 7.01, 9.01 · filed Apr 12, 2023 · filing
- Form 8-K · items 2.02, 9.01 · filed Mar 23, 2023 · filing
- Form 10-K · filed Mar 23, 2023 · filing